查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1600594

中心实验室市场：按服务类型、阶段、治疗领域和最终用途分类 - 全球预测 2025-2030

Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年，中心实验室市场价值为31.1亿美元，预计到2024年将达到33.8亿美元，复合年增长率为9.25%，到2030年将达到57.8亿美元。

中心实验室市场由实验室网路组成，透过提供标准化化验服务来支援临床试验，确保不同设施之间的测试一致且可靠。对于製药公司、生物技术公司和委外研发机构(CRO) 来说，实验室至关重要，因为它们提供加快药物开发过程的基本服务，例如集中资料、标准化测试程序和缩短交付时间。随着临床试验变得更加复杂和全球化，对中心实验室的需求不断增长，需要更严格地遵守监管标准并促进加强资料管理。主要应用是药物代谢测试、生物标记分析和伴同性诊断，特别是在肿瘤学和慢性病临床试验。市场开拓的驱动力是开发新药需求的增加、诊断检测技术的进步以及个人化医疗范围的扩大。存在机会扩展到新兴市场并利用基因组学和蛋白​​质组学的进步来提供更专业的服务。然而，市场成长面临严格的法律规范、高营运成本以及与各种临床试验设施的资料管理和整合相关的挑战等形式的限制。竞争因素包括潜在的资料隐私风险以及不断升级技术基础设施以保持竞争力的需求。需要探索的创新领域包括引入人工智慧和机器学习来增强资料分析、流程自动化和预测分析。此外，开发用于无缝资料传输的整合平台并与高科技公司合作以确保资料的安全处理可以带来可观的回报。中央实验室市场受到所面临的挑战、对创新治疗解决方案的持续需求以及将最尖端科技融入实验室服务的推动，相关人员不断创新和成长，我们为它们提供了绝佳的机会。

主要市场统计
基准年[2023] 31.1亿美元
预计年份 [2024] 33.8亿美元
预测年份 [2030] 57.8亿美元
复合年增长率（%） 9.25%

市场动态：揭示快速发展的中央实验室市场的关键市场洞察

供需的动态交互作用正在改变中央实验室市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 临床试验数量不断增加，药物开发活动的复杂性不断增加
    • 政府在全球推广精准医疗的倡议
  • 市场限制因素
    • 建立和维护中央研究实验室的成本高昂
  • 市场机会
    • 中心实验室技术整合及智慧化功能
    • 中央研究院设立及扩建投资
  • 市场挑战
    • 操作限制和标准化复杂性

波特五力：驾驭中央实验室市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解中央实验室市场的外部影响

外部宏观环境因素在塑造中央实验室市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解中心实​​验室市场的竞争状况

中央实验室市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵中央实验室市场供应商的绩效评估

FPNV定位矩阵是评估中心实验室市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。四个象限清楚且准确地划分供应商，帮助使用者辨识最能满足其策略目标的合作伙伴和解决方案。

本报告提供了涵盖关键重点领域的全面市场分析：

1. 市场渗透率：对当前市场环境的详细回顾，包括行业主要企业的大量资料。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监管核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 临床试验数量不断增加，药物开发活动的复杂性不断增加
      • 政府在全球推广精准医疗的倡议
    • 抑制因素
      • 建立和维护中心实验室的成本很高。
    • 机会
      • 中心实验室的技术整合和智慧功能
      • 投资建立与扩大中心实验室
    • 任务
      • 操作限制和标准化复杂性
  • 市场区隔分析
    • 服务类型：优先选择中心实验室在受控条件下长期保存生物样本进行专门管理
    • 阶段：中心实验室在整个临床试验过程执行中的关键作用
    • 最终用途：必须促进无缝临床试验，同时确保製药公司的资料完整性和卓越运营
    • 治疗领域：肿瘤和感染疾病治疗领域的综合诊断和预后检测
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 中心实验室市场：依服务类型

  • 解剖病理学/组织学
  • 生物标誌服务
  • 遗传服务
  • 微生物学服务
  • 特种化学品服务
  • 标本管理及储存

第七章 中心实验室市场分阶段

  • 第一阶段
  • 第二阶段
  • 第三阶段

第八章依治疗领域分類的中心实验室市场

  • 自体免疫疾病
  • 心血管疾病
  • 感染疾病
  • 神经病学
  • 肿瘤学

第 9 章 中心实验室市场：依最终用途分类

  • 学术研究所
  • 生技公司
  • 病理学和诊断实验室
  • 製药公司

第10章美洲的中心实验室市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太中心实验室市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的中心实验室市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • Medpace 中央实验室扩建新加坡工厂
    • Vial 宣布与 MLM Medical Labs 合作提供中央测试解决方案
    • Cerba Healthcare 收购加拿大合约研究组织 CIRION BioPharma Research，以扩大生物分析能力并减少进行复杂临床试验的时间
    • 克利夫兰诊所和 LabConnect 宣布建立策略联盟以改善患者照护
    • Versiti 收购总部位于印第安纳州的 Quantigen，以加速临床前研究服务的创新
    • Wispringhof 职业医学大学与 Labconnect 宣布策略合作伙伴关係—扩大全球中心实验室服务以加速药物开发
    • IQVIA 和 (RED) 宣布建立突破性伙伴关係，帮助增强实验室系统
    • Cerba Investigations 为化验服务合作伙伴提供客製化和创新的方法
    • Medpace 中心实验室扩大组织学和解剖病理学服务
    • Thermo Fisher 投资 5,900 万美元扩大美国临床研究实验室

公司名单

  • ACM Medical Laboratory, Inc.
  • Almac Group
  • Cerba HealthCare
  • CROMSOURCE by ClinChoice
  • Cryoport, Inc.
  • Eurofins Scientific SE
  • Exagen Inc.
  • Frontage Laboratories, Inc.
  • GBA Group
  • GCCL Co., Ltd.
  • ICON PLC
  • InterlabCorp
  • Intertek Group PLC
  • IQVIA Inc.
  • LabConnect, Inc.
  • Laboratory Corporation of America Holdings
  • Lambda Therapeutic Research Ltd.
  • Lotus Labs Pvt. Ltd. by Teva Pharmaceutical Industries Ltd.
  • MDS Pharma Services
  • Medicover AB
  • Medpace, Inc.
  • MLM Medical Labs GmbH
  • Novotech Health Holdings
  • Pace Analytical Services, LLC
  • Precision Medicine Group, LLC
  • Quest Diagnostics Incorporated
  • REPROCELL Inc.
  • SGS SA
  • Shanghai Clinical Research Center
  • SMS Pharmaceuticals Ltd.
  • Sonic Healthcare International
  • Syngene International Limited
  • Thermo Fisher Scientific Inc.
  • Unilabs AB
  • Versiti, Inc.
  • WuXi AppTec
Product Code: MRR-F927BA462EBB

The Central Lab Market was valued at USD 3.11 billion in 2023, expected to reach USD 3.38 billion in 2024, and is projected to grow at a CAGR of 9.25%, to USD 5.78 billion by 2030.

The Central Lab market comprises a network of laboratories that support clinical trials by providing standardized laboratory services, ensuring consistent and reliable testing across different sites. These labs are crucial for pharmaceutical companies, biotech firms, and contract research organizations (CROs) as they offer centralization of data, uniformity in testing procedures, and reduction in turnaround times-vital for speeding up drug development processes. The necessity for central labs has grown with the increasing complexity and globalization of clinical trials, requiring strict adherence to regulatory standards and facilitating enhanced data management. Applications mainly encompass drug metabolism studies, biomarker analyses, and companion diagnostics, especially in oncology and chronic disease trials. The market's growth is driven by heightened demand for new drug development, technological advancements in diagnostic testing, and a broader scope for personalized medicine. Opportunities lie in the expansion into emerging markets and leveraging advancements in genomics and proteomics to offer more specialized services. However, market growth faces limitations in the form of stringent regulatory frameworks, high operational costs, and challenges associated with data management and integration across various trial sites. Adverse factors include potential risks related to data privacy and the need for constantly upgrading technological infrastructure to stay competitive. Innovative areas to explore include the incorporation of artificial intelligence and machine learning to enhance data analysis, process automation, and predictive analytics. Moreover, developing integrated platforms for seamless data transfer and partnering with tech companies to ensure secure data handling could offer significant returns. The Central Lab market, while facing challenges, presents robust opportunities for stakeholders to innovate and grow, largely driven by the continuous demand for innovative therapeutic solutions and the integration of cutting-edge technologies into laboratory services.

KEY MARKET STATISTICS
Base Year [2023] USD 3.11 billion
Estimated Year [2024] USD 3.38 billion
Forecast Year [2030] USD 5.78 billion
CAGR (%) 9.25%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Central Lab Market

The Central Lab Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in the number of clinical trials and complexity of drug development activities
    • Government initiatives promoting precision medicine worldwide
  • Market Restraints
    • High cost of set-up and maintenance of central labs
  • Market Opportunities
    • Technological integrations and smart features in central labs
    • Investments for establishment and expansion of central labs
  • Market Challenges
    • Operational limitations and standardization complexities

Porter's Five Forces: A Strategic Tool for Navigating the Central Lab Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Central Lab Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Central Lab Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Central Lab Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Central Lab Market

A detailed market share analysis in the Central Lab Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Central Lab Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Central Lab Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Central Lab Market, highlighting leading vendors and their innovative profiles. These include ACM Medical Laboratory, Inc., Almac Group, Cerba HealthCare, CROMSOURCE by ClinChoice, Cryoport, Inc., Eurofins Scientific SE, Exagen Inc., Frontage Laboratories, Inc., GBA Group, GCCL Co., Ltd., ICON PLC, InterlabCorp, Intertek Group PLC, IQVIA Inc., LabConnect, Inc., Laboratory Corporation of America Holdings, Lambda Therapeutic Research Ltd., Lotus Labs Pvt. Ltd. by Teva Pharmaceutical Industries Ltd., MDS Pharma Services, Medicover AB, Medpace, Inc., MLM Medical Labs GmbH, Novotech Health Holdings, Pace Analytical Services, LLC, Precision Medicine Group, LLC, Quest Diagnostics Incorporated, REPROCELL Inc., SGS S.A., Shanghai Clinical Research Center, SMS Pharmaceuticals Ltd., Sonic Healthcare International, Syngene International Limited, Thermo Fisher Scientific Inc., Unilabs AB, Versiti, Inc., and WuXi AppTec.

Market Segmentation & Coverage

This research report categorizes the Central Lab Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Service Type, market is studied across Anatomic Pathology/Histology, Biomarker Services, Genetic Services, Microbiology Services, Special Chemistry Services, and Specimen Management & Storage.
  • Based on Phase, market is studied across Phase 1, Phase 2, and Phase 3.
  • Based on Therapeutic Area, market is studied across Autoimmune Diseases, Cardiovascular Diseases, Infectious Diseases, Neurology, and Oncology.
  • Based on End-use, market is studied across Academic & Research Institutes, Biotechnology Companies, Pathology & Diagnostic Lab, and Pharmaceutical Companies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the number of clinical trials and complexity of drug development activities
      • 5.1.1.2. Government initiatives promoting precision medicine worldwide
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of set-up and maintenance of central labs
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological integrations and smart features in central labs
      • 5.1.3.2. Investments for establishment and expansion of central labs
    • 5.1.4. Challenges
      • 5.1.4.1. Operational limitations and standardization complexities
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Services Type: Preference for central labs for long-term storage of biological samples under controlled conditions for specific management
    • 5.2.2. Phase: Integral role of the central labs for the execution of the entire clinical trial process
    • 5.2.3. End-use: Need to facilitate seamless clinical trials, ensuring data integrity and operational excellence for pharmaceutical companies
    • 5.2.4. Therapeutic Area: Comprehensive diagnostic and prognostic testing for oncology and infectious diseases therapeutic areas
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Central Lab Market, by Service Type

  • 6.1. Introduction
  • 6.2. Anatomic Pathology/Histology
  • 6.3. Biomarker Services
  • 6.4. Genetic Services
  • 6.5. Microbiology Services
  • 6.6. Special Chemistry Services
  • 6.7. Specimen Management & Storage

7. Central Lab Market, by Phase

  • 7.1. Introduction
  • 7.2. Phase 1
  • 7.3. Phase 2
  • 7.4. Phase 3

8. Central Lab Market, by Therapeutic Area

  • 8.1. Introduction
  • 8.2. Autoimmune Diseases
  • 8.3. Cardiovascular Diseases
  • 8.4. Infectious Diseases
  • 8.5. Neurology
  • 8.6. Oncology

9. Central Lab Market, by End-use

  • 9.1. Introduction
  • 9.2. Academic & Research Institutes
  • 9.3. Biotechnology Companies
  • 9.4. Pathology & Diagnostic Lab
  • 9.5. Pharmaceutical Companies

10. Americas Central Lab Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Central Lab Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Central Lab Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. Medpace Central Labs Expand Singapore Facility
    • 13.3.2. Vial Announces Collaborative Alliance with MLM Medical Labs for offering Central Laboratory Solutions
    • 13.3.3. Cerba HealthCare to Acquire Canadian Contract Research Laboratory CIRION BioPharma Research to Expand Bioanalytical Capabilities and Shorten Time-to-Deploy Complex Clinical Trials
    • 13.3.4. Cleveland Clinic and LabConnect announce Strategic Alliance for Improved Patient Care
    • 13.3.5. Versiti Acquires Indiana-based Quantigen for Accelerating Pace of Innovation for Preclinical Research Services
    • 13.3.6. Labor Dr. Wisplinghoff and Labconnect Announce Strategic Alliance - Expanding Global Central Laboratory Services to Accelerate the Development of Medicines
    • 13.3.7. IQVIA & (RED) Announce Groundbreaking Partnership to Support Laboratory System Strengthening
    • 13.3.8. Cerba Research Offers a Customized, Innovative Approach to its Partners in the Laboratory Services
    • 13.3.9. Medpace Central Labs Expand Histology & Anatomic Pathology Services
    • 13.3.10. Thermo Fisher to invest USD 59 Million for Clinical Research Lab Expansion in the U.S.

Companies Mentioned

  • 1. ACM Medical Laboratory, Inc.
  • 2. Almac Group
  • 3. Cerba HealthCare
  • 4. CROMSOURCE by ClinChoice
  • 5. Cryoport, Inc.
  • 6. Eurofins Scientific SE
  • 7. Exagen Inc.
  • 8. Frontage Laboratories, Inc.
  • 9. GBA Group
  • 10. GCCL Co., Ltd.
  • 11. ICON PLC
  • 12. InterlabCorp
  • 13. Intertek Group PLC
  • 14. IQVIA Inc.
  • 15. LabConnect, Inc.
  • 16. Laboratory Corporation of America Holdings
  • 17. Lambda Therapeutic Research Ltd.
  • 18. Lotus Labs Pvt. Ltd. by Teva Pharmaceutical Industries Ltd.
  • 19. MDS Pharma Services
  • 20. Medicover AB
  • 21. Medpace, Inc.
  • 22. MLM Medical Labs GmbH
  • 23. Novotech Health Holdings
  • 24. Pace Analytical Services, LLC
  • 25. Precision Medicine Group, LLC
  • 26. Quest Diagnostics Incorporated
  • 27. REPROCELL Inc.
  • 28. SGS S.A.
  • 29. Shanghai Clinical Research Center
  • 30. SMS Pharmaceuticals Ltd.
  • 31. Sonic Healthcare International
  • 32. Syngene International Limited
  • 33. Thermo Fisher Scientific Inc.
  • 34. Unilabs AB
  • 35. Versiti, Inc.
  • 36. WuXi AppTec

LIST OF FIGURES

  • FIGURE 1. CENTRAL LAB MARKET RESEARCH PROCESS
  • FIGURE 2. CENTRAL LAB MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL CENTRAL LAB MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL CENTRAL LAB MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CENTRAL LAB MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL CENTRAL LAB MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES CENTRAL LAB MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES CENTRAL LAB MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. CENTRAL LAB MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. CENTRAL LAB MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. CENTRAL LAB MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL CENTRAL LAB MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CENTRAL LAB MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CENTRAL LAB MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CENTRAL LAB MARKET DYNAMICS
  • TABLE 7. GLOBAL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CENTRAL LAB MARKET SIZE, BY ANATOMIC PATHOLOGY/HISTOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CENTRAL LAB MARKET SIZE, BY BIOMARKER SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CENTRAL LAB MARKET SIZE, BY GENETIC SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CENTRAL LAB MARKET SIZE, BY MICROBIOLOGY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CENTRAL LAB MARKET SIZE, BY SPECIAL CHEMISTRY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CENTRAL LAB MARKET SIZE, BY SPECIMEN MANAGEMENT & STORAGE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 1, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 2, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CENTRAL LAB MARKET SIZE, BY PHASE 3, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CENTRAL LAB MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CENTRAL LAB MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CENTRAL LAB MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CENTRAL LAB MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CENTRAL LAB MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CENTRAL LAB MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CENTRAL LAB MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CENTRAL LAB MARKET SIZE, BY PATHOLOGY & DIAGNOSTIC LAB, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CENTRAL LAB MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS CENTRAL LAB MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. MEXICO CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. UNITED STATES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. UNITED STATES CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES CENTRAL LAB MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 55. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 57. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC CENTRAL LAB MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 60. AUSTRALIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. AUSTRALIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 62. AUSTRALIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 63. AUSTRALIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. CHINA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. CHINA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 66. CHINA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 67. CHINA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 68. INDIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 70. INDIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 71. INDIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. INDONESIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. INDONESIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 74. INDONESIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 75. INDONESIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. JAPAN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. JAPAN CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 78. JAPAN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 79. JAPAN CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 80. MALAYSIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. MALAYSIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 82. MALAYSIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 83. MALAYSIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 84. PHILIPPINES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. PHILIPPINES CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 86. PHILIPPINES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 87. PHILIPPINES CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 88. SINGAPORE CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SINGAPORE CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 90. SINGAPORE CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 91. SINGAPORE CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 94. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 95. SOUTH KOREA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 96. TAIWAN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. TAIWAN CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 98. TAIWAN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 99. TAIWAN CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 100. THAILAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. THAILAND CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 102. THAILAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 103. THAILAND CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. VIETNAM CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. VIETNAM CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 106. VIETNAM CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 107. VIETNAM CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 108. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 110. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 111. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. EUROPE, MIDDLE EAST & AFRICA CENTRAL LAB MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 113. DENMARK CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. DENMARK CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 115. DENMARK CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 116. DENMARK CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. EGYPT CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. EGYPT CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 119. EGYPT CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 120. EGYPT CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 121. FINLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FINLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 123. FINLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 124. FINLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. FRANCE CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. FRANCE CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 127. FRANCE CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 128. FRANCE CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 129. GERMANY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. GERMANY CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 131. GERMANY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 132. GERMANY CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 133. ISRAEL CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ISRAEL CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 135. ISRAEL CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 136. ISRAEL CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. ITALY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. ITALY CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 139. ITALY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 140. ITALY CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 141. NETHERLANDS CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NETHERLANDS CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 143. NETHERLANDS CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 144. NETHERLANDS CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 145. NIGERIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NIGERIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 147. NIGERIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 148. NIGERIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. NORWAY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. NORWAY CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 151. NORWAY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 152. NORWAY CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. POLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. POLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 155. POLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 156. POLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 157. QATAR CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. QATAR CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 159. QATAR CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 160. QATAR CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 161. RUSSIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. RUSSIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 163. RUSSIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 164. RUSSIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 165. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 167. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 168. SAUDI ARABIA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 169. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 171. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 172. SOUTH AFRICA CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. SPAIN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SPAIN CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 175. SPAIN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 176. SPAIN CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 177. SWEDEN CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWEDEN CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 179. SWEDEN CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 180. SWEDEN CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 181. SWITZERLAND CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. SWITZERLAND CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 183. SWITZERLAND CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 184. SWITZERLAND CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 185. TURKEY CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. TURKEY CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 187. TURKEY CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 188. TURKEY CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 191. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 192. UNITED ARAB EMIRATES CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY SERVICE TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY PHASE, 2018-2030 (USD MILLION)
  • TABLE 195. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY THERAPEUTIC AREA, 2018-2030 (USD MILLION)
  • TABLE 196. UNITED KINGDOM CENTRAL LAB MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 197. CENTRAL LAB MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 198. CENTRAL LAB MARKET, FPNV POSITIONING MATRIX, 2023